Vitae Pharmaceuticals Company Profile

09:20 EST 29th January 2015 | BioPortfolio

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery programs. Vitae's goal is to discover, develop and commercialize innovative new medicines that will be best-in-class for important disease areas, such as cardiovascular diseases, cancer and dermatology.We are focused on the development of compounds for high value, well validated biological targets. In our discovery and development processes, we seek to leverage available existing clinical and / or preclinical knowledge to efficiently and effectively create novel drug candidates that can address clear unmet therapy needs. Vitae's unique product engine combines the drug discovery skills of proven, deeply experienced drug hunters with state-of-the-art proprietary drug design technologies. This integrated and entrepreneurial approach improves the quality and innovativeness of the compounds we discover, while dramatically shortening the time required to bring them to the clinic.We have demonstrated the ability to rapidly advance novel compounds into clinical development, as Vitae now has clinical candidates in three therapeutic areas, two of which are in clinical studies and a pipeline of additional promising compounds.


502 West Office Center
Drive Fort Washington
United States of America


Phone: (215) 461-2000
Fax: (215) 461-2006

News Articles [33 Associated News Articles listed on BioPortfolio]

Stifel starts Vitae Pharma at buy

Stifel has initiated coverage of Vitae Pharmaceuticals (NASDAQ:VTAE) with a “buy” rating and price target of $14. The stock closed at $6.30 on Friday. “Vitae’s unique technology platform encom...

Vitae prices IPO below range

Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) was down $0.39 to $7.61 in its first day of trading Wednesday after raising $55 million through the sale of 6.9 million shares at $8 in an IPO on NASDAQ. The I...

Vitae Pharmaceuticals plans IPO

Vitae Pharmaceuticals Inc. (structure-based drug discovery in multiple therapeutic areas) filed for its IPO on Nasdaq.

Vitae Pharmaceuticals nets $51.2mm in IPO

Vitae Pharmaceuticals Inc. (structure-based drug discovery in multiple therapeutic areas) netted $51.2mm in its IPO of 6.9mm shares (higher than the 5mm planned) at $8, below the $11-13 target range. ...

Vitae sets IPO terms

Vitae Pharmaceuticals Inc. (Fort Washington, Pa.) set the terms for its IPO on NASDAQ. The company plans to sell 5 million shares at $11-$13. At the $12 midpoint, Vitae would raise $60 million and be ...

Vitae Obtains Proof-Of-Mechanism Data For BACE Inhibition In Alzheimer’s

Two programs partnered with Germany’s Boehringer Ingelheim are advancing, with a type 2 diabetes program moving into Phase II while a BACE inhibitor for Alzheimer’s offers demonstrates strong abil...

Vitae nets $33.6mm via FOPO

In its first FOPO since going public four months ago, Vitae Pharmaceuticals Inc. (developed the Contour structure-based drug discovery platform) netted $33.6mm through the follow-on public offering of...

Vitae files for IPO

Vitae Pharmaceuticals Inc. (Fort Washington, Pa.) filed to raise up to $55 million in an IPO on NASDAQ underwritten by Stifel; BMO Capital Markets; JMP Securities; and Wedbush PacGrow. Vitae's lead co...

Drugs and Medications [0 Results]


PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe.

The medicinal chemistry and biomedical applications of gold complexes have been intensively studied over the last decades. Some complexes have been used for the treatment of rheumatoid arthritis, and ...

The Curriculum Vitae: Gateway to Academia.

The physiologist Ewald Hering (1834-1918): Curriculum vitae.

The physiologist Ewald Hering (1834-1918): Curriculum vitae.

Samuel Goldflam (1852-1932) - promoter of modern neurology and his contribution to urology.

The work of Samuel Goldflam is well known among urologists and nephrologists but his name also holds a special significance to the development of several specialist disciplines of modern medicine. A s...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)

The aim of the study is to evaluate toxicity and effectiveness of electrochemotherapy with bleomycin in treatment of primary liver tumors in clinical study phase I and II. The study will ...

Companies [7 Associated Companies listed on BioPortfolio]

Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including...

Vitae Pharmaceuticals

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery pr...

CV Index

The CV Index provides a permanent, web presence & management centre for your Curriculum Vitae (Resume), which is freely searchable on our powerful CVs search engine, wherever you are in the world. Ch...


Our Profile represents an introductory overview of the key facts investors need to know about BB MEDTECH. The various ticker symbols are also available here. Click on Board of Directors and Management...

BitTech, Inc

BitTech, Inc. is a biotechnology company that focuses on the identification and initiation of research which has the potential to lead to enabling technology. BitTech was founded by Grant A. Bitter, ...

More Information about "Vitae Pharmaceuticals" on BioPortfolio

We have published hundreds of Vitae Pharmaceuticals news stories on BioPortfolio along with dozens of Vitae Pharmaceuticals Clinical Trials and PubMed Articles about Vitae Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vitae Pharmaceuticals Companies in our database. You can also find out about relevant Vitae Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:

Relevant Topics

Alzheimer's Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks

Searches Linking to this Company Record